"Bank of China report" Citi downgraded Ping an good Doctor (01833.HK) target price to 35 yuan rating "buy"
According to a research report released by Citigroup, the income of Ping an good Doctor (01833.HK) fell 21.4 per cent year-on-year to 2.222 billion yuan in the first half, 26 per cent and 30 per cent lower than market expectations and bank expectations respectively, while the net loss was 245 million yuan, narrowed from the 462 million yuan loss in the same period last year and better than expected. The gross profit margin increased to 32.2% from 27.3% in the first half of last year, mainly due to the strategic shift from low-profit business to high-profit business.
The bank cut its income forecast for Ping an good doctors by 25 per cent, 23 per cent and 20 per cent from 2023 to 2025 to reflect falling earnings from withdrawing from lower gross margins. The target price was lowered from $40 to $35, maintaining the "buy" rating.
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.